Biohaven Pharmaceutical Holding Company Ltd.
CGRP ANTAGONISTS FOR TREATING MIGRAINE BREAKTHROUGH

Last updated:

Abstract:

Disclosed are methods of treating breakthrough migraine in patients using breakthrough CGRP antagonists. Also disclosed are methods for the prophylactic treatment of migraine.

Status:
Application
Type:

Utility

Filling date:

19 Jan 2020

Issue date:

4 Nov 2021